Skip to content

t:slim X2 Insulin Pump with Control-IQ TechnologyRecalls & reported problems across all models

Tandem Diabetes Care, Inc. · 11 models in the FDA device registry

Data updated Oct 16, 2026 from official FDA records · Editorial policy

3 open recalls name at least one t:slim X2 Insulin Pump with Control-IQ Technology model. Check whether yours is affected in the recall details, and contact the manufacturer or your healthcare provider.

Adverse event reports
126,966
Deaths reported
33
Injuries reported
17,519
Recalls
3

We found 11 models of t:slim X2 Insulin Pump with Control-IQ Technology by Tandem Diabetes Care, Inc. in the FDA's device registry (GUDID). Together they are named in 126,966 adverse event reports in the FDA's MAUDE database, received between Dec 28, 2023 and Sep 30, 2026 — classified as 33 deaths, 17,519 injuries, 109,414 malfunctions.

The most frequently reported specific device problem is “Pumping Stopped” (45,666 reports).

3 FDA recall records name at least one of these models by its device identifier, 3 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works

Reports received per month, all models

Nov 2023: 0 reportsDec 2023: 1 reportsJan 2024: 108 reportsFeb 2024: 460 reportsMar 2024: 901 reportsApr 2024: 1,445 reportsMay 2024: 1,593 reportsJun 2024: 1,911 reportsJul 2024: 2,810 reportsAug 2024: 2,971 reportsSep 2024: 3,459 reportsOct 2024: 3,912 reportsNov 2024: 3,206 reportsDec 2024: 3,317 reportsJan 2025: 5,739 reportsFeb 2025: 3,396 reportsMar 2025: 4,769 reportsApr 2025: 3,692 reportsMay 2025: 5,226 reportsJun 2025: 4,259 reportsJul 2025: 7,259 reportsAug 2025: 6,344 reportsSep 2025: 4,160 reportsOct 2025: 4,330 reportsNov 2025: 5,609 reportsDec 2025: 7,530 reportsJan 2026: 6,450 reportsFeb 2026: 6,311 reportsMar 2026: 6,565 reportsApr 2026: 6,259 reportsMay 2026: 4,788 reportsJun 2026: 4,676 reportsJul 2026: 1,685 reportsAug 2026: 881 reportsSep 2026: 944 reportsOct 2026: 0 reports2024202520267,530
Last 36 months. The most recent month may be incomplete.

t:slim X2 Insulin Pump with Control-IQ Technology recalls

FDA recall records that name at least one of these models by its device identifier, newest first. Each recall usually covers specific models or lots, so check the details.

  1. Aug 5, 2025Class IIOpen, Classified

    A software defect in versions 7.9.0.1 and 7.10.1 of the pump software for Tandem t:slim X2 and version 7.9.0.1 of the Tandem Mobi pump with Control-IQ+ technology that are paired with a G7 sensor may result in an unexpected automatic insulin correction bolus (autobolus ) which could result in hypoglycemia.

    Z-0232-2026 · Root cause: Software change control · names 4 of these models · Recall details · FDA record ↗

  2. Jul 21, 2025Class IOpen, Classified

    Insulin pumps manufactured with speakers from Revision A and B may malfunction ("Malfunction 16") which prevents audible alerts and causes the pumps to become inoperable and stop infusing insulin which could result in a hyperglycemic event, which may lead to injury and/or hospitalization.

    Z-2343-2025 · Root cause: Nonconforming Material/Component · names 7 of these models · Recall details · FDA record ↗

  3. Feb 27, 2025Class IOpen, Classified

    A software defect in Version 7.9 of the pump software for Tandem t:slim X2 and Tandem Mobi pumps, when used with Control IQ+ technology, will cause the pump to incorrectly interpolate glucose trends when the Estimated Glucose Value (EGV) is above 255 mg/dL at the start or end of a gap in data collection due to a lapse in connection from a paired continuous glucose monitor (CGM) sensor, which can lead to under-delivery or over-delivery of insulin based on inaccurate result leading to severe cases of hypoglycemia or hyperglycemia.

    Z-1519-2025 · Root cause: Software Design Change · Recall details · FDA record ↗

Most reported t:slim X2 Insulin Pump with Control-IQ Technology problems

Device problems

  • Pumping Stopped45,666
  • Incorrect Measurement11,486
  • Charging Problem9,927
  • Adverse Event Without Identified Device or Use Problem8,256
  • Obstruction of Flow7,552
  • Failure to Charge7,371
  • Communication or Transmission Problem4,918
  • Battery Problem4,584

Patient problems

  • No Clinical Signs, Symptoms or Conditions109,514
  • Hyperglycemia12,681
  • Hypoglycemia4,662
  • Elevated Ketones/ Diabetic Ketoacidosis731
  • Loss of consciousness304
  • Insufficient Information227
  • Fall102
  • Vomiting62

t:slim X2 Insulin Pump with Control-IQ Technology models

11 models, most reported first. Each model has its own page with its reports, recalls and device details.

Recent t:slim X2 Insulin Pump with Control-IQ Technology adverse event reports

The 15 most recent reports across all models, in the reporter's own words as published by the FDA.

Other Tandem Diabetes Care, Inc. products

All Tandem Diabetes Care, Inc. devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page